181 related articles for article (PubMed ID: 17682303)
21. Successful treatment of syncope in head and neck cancer with induction chemotherapy.
Choi YM; Mafee MF; Feldman LE
J Clin Oncol; 2006 Nov; 24(33):5332-3. PubMed ID: 17114669
[No Abstract] [Full Text] [Related]
22. Randomized phase 2 study of concomitant chemoradiotherapy using weekly carboplatin/paclitaxel with or without daily subcutaneous amifostine in patients with locally advanced head and neck cancer.
Haddad R; Sonis S; Posner M; Wirth L; Costello R; Braschayko P; Allen A; Mahadevan A; Flynn J; Burke E; Li Y; Tishler RB
Cancer; 2009 Oct; 115(19):4514-23. PubMed ID: 19634161
[TBL] [Abstract][Full Text] [Related]
23. Induction chemotherapy followed by concurrent chemoradiotherapy in advanced head and neck squamous cell carcinoma.
Barone C; Grillo R; Dongiovanni D; Birocco N; Rampino M; Redda MG; Garibaldi E; Munoz F; Pecorari G; Cavalot A; Garzinodemo P; Buffoni L; Ciuffreda L; Ricardi U; Cortesina G; Giordano C; Fasolis M; Berrone S; Bertetto O; Schena M
Anticancer Res; 2008; 28(2B):1285-91. PubMed ID: 18505067
[TBL] [Abstract][Full Text] [Related]
24. Long-term survival of resectable subset after induction chemotherapy in patients with locally advanced head and neck cancer.
Cho YH; Lee SH; Kim DW; Wu HG; Hah JH; Rhee CS; Sung MW; Kim KH; Heo DS
Head Neck; 2008 Mar; 30(3):346-50. PubMed ID: 17972310
[TBL] [Abstract][Full Text] [Related]
25. Prognostic value of tumor regression during radiotherapy or chemoradiotherapy for advanced head and neck cancers: regarding Jaulerry et al. IJROBP 33(2):271-279; 1995.
Vikram B
Int J Radiat Oncol Biol Phys; 1996 Mar; 34(4):971. PubMed ID: 8598382
[No Abstract] [Full Text] [Related]
26. [Radiochemotherapy in head and neck neoplasms].
Munker R; Reitmeier M; Hartenstein R
Strahlenther Onkol; 2000 Nov; 176(11):537-8. PubMed ID: 11143531
[No Abstract] [Full Text] [Related]
27. Head and neck cancer.
Taylor SG
Cancer Chemother Biol Response Modif; 1997; 17():428-43. PubMed ID: 9551224
[No Abstract] [Full Text] [Related]
28. Nutritional factors as predictors of response to radio-chemotherapy and survival in unresectable squamous head and neck carcinoma.
Salas S; Deville JL; Giorgi R; Pignon T; Bagarry D; Barrau K; Zanaret M; Giovanni A; Bourgeois A; Favre R; Duffaud F
Radiother Oncol; 2008 May; 87(2):195-200. PubMed ID: 18342966
[TBL] [Abstract][Full Text] [Related]
29. Combined chemotherapy and intensity-modulated radiotherapy for the treatment of head and neck cancers.
Bhide SA; Newbold KL; Harrington KJ; Nutting CM
Expert Rev Anticancer Ther; 2010 Mar; 10(3):297-300. PubMed ID: 20214509
[No Abstract] [Full Text] [Related]
30. Use of chemotherapy in the management of advanced head and neck cancers.
Giri PG
Kans Med; 1991 Dec; 92(12):311-3, 316. PubMed ID: 1800820
[No Abstract] [Full Text] [Related]
31. Phase II trial of concurrent chemoradiotherapy with S-1 plus cisplatin in patients with unresectable locally advanced squamous cell carcinoma of the head and neck: Japan Clinical Oncology Group Study (JCOG0706).
Nakamura K; Tahara M; Kiyota N; Hayashi R; Akimoto T; Fukuda H; Fujii M; Boku N
Jpn J Clin Oncol; 2009 Jul; 39(7):460-3. PubMed ID: 19429640
[TBL] [Abstract][Full Text] [Related]
32. Head and neck cancer.
Taylor SG
Cancer Chemother Biol Response Modif; 2001; 19():465-83. PubMed ID: 11686028
[No Abstract] [Full Text] [Related]
33. Neoadjuvant chemotherapy of cisplatin and fluorouracil regimen in head and neck squamous cell carcinoma: a meta-analysis.
Su YX; Zheng JW; Zheng GS; Liao GQ; Zhang ZY
Chin Med J (Engl); 2008 Oct; 121(19):1939-44. PubMed ID: 19080128
[TBL] [Abstract][Full Text] [Related]
34. [The present situation of neoadjuvant therapy for head and neck carcinoma].
Rikimaru F; Tomita K
Gan To Kagaku Ryoho; 2007 Oct; 34(10):1535-7. PubMed ID: 17940367
[TBL] [Abstract][Full Text] [Related]
35. Head and neck cancer.
Taylor SG
Cancer Chemother Biol Response Modif; 1992; 13():440-54. PubMed ID: 1389916
[No Abstract] [Full Text] [Related]
36. The role of induction chemotherapy in advanced head and neck cancer: the Wayne State University experience.
Kish JA; Ensley J; Crissman J; Weaver A; Jacobs J; Kinzie J; Al-Sarraf M
Prog Clin Biol Res; 1985; 201():177-89. PubMed ID: 4095109
[No Abstract] [Full Text] [Related]
37. Hyperfractionated accelerated radiotherapy versus conventional fractionation both combined with chemotherapy in patients with locally advanced head and neck carcinomas: a retrospective analysis of a monoinstitutional series.
Welz H; Pöttgen C; Abu Jawad J; Wierlemann A; Wittig A; Stüben G; Budach V; Lehnerdt G; Jahnke K; Sack H; Stuschke M
Oncology; 2009; 76(6):405-12. PubMed ID: 19407473
[TBL] [Abstract][Full Text] [Related]
38. Preliminary results of a prospective randomized trial comparing concurrent chemoradiotherapy plus adjuvant chemotherapy with radiotherapy alone in patients with locoregionally advanced nasopharyngeal carcinoma in endemic regions of china.
Chen Y; Liu MZ; Liang SB; Zong JF; Mao YP; Tang LL; Guo Y; Lin AH; Zeng XF; Ma J
Int J Radiat Oncol Biol Phys; 2008 Aug; 71(5):1356-64. PubMed ID: 18472356
[TBL] [Abstract][Full Text] [Related]
39. Does concurrent postoperative radiotherapy and chemotherapy in head and neck cancer improve patient outcome?
Yom SS; Rosenthal DI
Nat Clin Pract Oncol; 2004 Nov; 1(1):14-5. PubMed ID: 16264790
[No Abstract] [Full Text] [Related]
40. Advances in radiation therapy of head and neck cancer.
Popovtzer A; Eisbruch A
Expert Rev Anticancer Ther; 2008 Apr; 8(4):633-44. PubMed ID: 18402530
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
